Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Mol Neurobiol. 2015 May 8;53(5):2983–2994. doi: 10.1007/s12035-015-9179-1

Figure 1.

Figure 1

DMPO enters the brain after intraperitoneal injections. (A) HPLC chromatogram showing a peak corresponding to DMPO in brain and liver homogenates after 2 hours of DMPO injections (2g/kg, i.p.). (B) MS spectra showing peaks with m/z of 114.09, indicating the presence of DMPO in brain homogenates after intraperitoneal injections.